Tefron Follow-Up: Customer Concentration And The U.S. Tariff Test

Not a Side Note, but the Core Commercial Dependency

The main article argued that retail kept Tefron standing while the brands business weakened. This follow-up isolates the narrower issue that decides how durable that stability really is: what it means when 64.7% of revenue sits with three customers, when Wal-Mart and Target alone account for 49.5% of sales, and when that same customer base is operating inside a U.S. tariff regime that keeps shifting.

This is not only concentration. It is a bargaining-power test. Management's presentation highlights strong relationships with key customers. The annual business review describes a harder structure underneath: the relationship with material customers is usually governed by a general agreement drafted unilaterally by the customer, it is not time-limited, it gives Tefron no exclusivity, and in practice it rests on purchase orders that arrive from time to time. In that setup, customer concentration is not just a comfort metric. It determines who comes into the next shock with more leverage.

The more interesting point is not only the level but the direction. After easing to 56.5% in 2024, the top three customers moved back up to 64.7% of revenue in 2025. Wal-Mart went back up to 27.7%, Customer C jumped to 15.2%, and that third customer is still not named even though it represented more than $35.9 million of revenue. This matters because the report itself says explicitly that a significant decline in sales to the material customers, especially those above 20% of sales, would have a very material adverse effect on results.

The Customer Influences Terms, Not Only Volume

A large customer relationship is not measured only by the revenue line. It is also measured by who sets the terms. Payment terms with Tefron's material customers run between 60 and 120 days from delivery and invoice issuance, but with Wal-Mart and Target the company uses an early-payment mechanism in exchange for interest, shortening the effective payment period to up to 30 days. In plain terms, part of what looks like strong customer stickiness also rests on Tefron paying an economic price to accelerate cash collection.

This is not just a financing side note. To support working-capital needs, especially in retail, the company receives open credit from significant subcontractors in China and also uses customer payment-acceleration programs. At the same time, the annual report says that some of the suppliers used by the company are dictated by customers. In other words, the large customer affects not only demand volume but also procurement, operations, and part of the funding structure around the relationship.

So the relationships are strong, but they are not symmetrical. That is why it is too easy to read anchor customers as a clean moat. In Tefron's case they are also a mechanism that forces the company to stay commercially flexible, and sometimes to help finance that flexibility.

The Tariffs Showed Who Really Carries the Pain

This is where the continuation becomes sharper. The company estimates that the new U.S. tariff policy reduced 2025 pretax profit by about $3 million, and that roughly $1.5 million of that hit was concentrated in the fourth quarter alone. That is a large number relative to the reported result: pretax profit for 2025 was only $5.021 million, and in the fourth quarter it fell to just $123 thousand. So in Q4 alone, the estimated tariff hit was materially larger than the quarter's reported pretax profit.

The company also says it is trying to reduce the impact by shifting production from China to other countries and through participation by suppliers and customers in part of the extra cost. The key word is "part." If customers were carrying most of the burden, one would expect the Q4 improvement in retail sales to show up in healthier profitability as well. That is not what happened.

In the fourth quarter, retail revenue rose 12.4% to $40.608 million, mainly because sales to the segment's material customers increased by 26% on a net basis. Average selling price rose 17% because of mix, yet gross margin still fell to 20.0% from 20.9%. The same pattern exists at the annual level: retail sales fell 9.5%, gross profit fell 10.6%, and gross margin slipped from 22.5% to 22.2%, with the company stating that the main tariff effect started in the third quarter.

The important point is not only that tariffs hurt. That part is obvious. The important point is that the pain appeared inside the segment that was supposed to be the steadier engine, and it appeared even in a quarter when the material customers came back with stronger ordering. That suggests the large-customer relationship protected volume better than it protected margin. In the real test of 2025, Tefron was not able to pass through the full shock.

The Order Book Gives a Short Window, Not a Wall of Protection

The reason this concentration is especially sensitive also sits in the order pattern. In retail, the company receives both specific orders and replenishment orders, while holding inventory in warehouses for customers for an average of 6 to 15 weeks, with customers typically placing the purchase order close to the draw date. The company also writes explicitly that because of the industry structure, the order pattern, and the frequent tariff changes in 2025, its order book covers only a relatively short period and does not give a full indication of actual orders for the year.

* The first-quarter figure at March 25, 2026 includes both order backlog and sales already executed in Q1.

At first glance, that table looks reassuring. By March 25, 2026 the retail picture was much fuller than it looked at year-end. But this is exactly where the weakness sits. The March view is not a clean backlog snapshot. In the first quarter it already includes sales that were actually executed, and the company also makes clear that the forecasts it receives from most leading customers are non-binding.

That means Tefron does not have a full-year wall of locked-in demand here. It has a relatively short visibility window. In that structure, a large customer can strengthen the next quarter quickly, but it can also change mix, delay draws, or push on terms quickly. That is why customer concentration and tariff risk are not two separate issues. They amplify each other.

Bottom Line: The Large Customer Buys the Volume, Not the Quiet

Management's presentation chooses to stress two assets: strong relationships with key customers and the competitive advantage of the manufacturing footprint in Jordan and Romania. Those are the two pillars management puts at the center of its case. The annual report also points to efforts to move production away from China, and the U.S. court ruling opened a possible path to tariff refunds in the future. But these are relief valves for now, not a solution to the underlying power structure.

The follow-up thesis is simple: at Tefron, customer concentration is not just the risk of losing a customer. It is the mechanism that decides who actually carries the burden when the market shifts. In 2025 that mechanism preserved retail volume in the fourth quarter, but it did not prevent a meaningful hit to profitability, and the company itself says suppliers and customers are sharing only part of the added cost.

So the real 2026 test is not only whether Wal-Mart and Target keep buying. It is whether Tefron can prove that the move away from China, together with broader cost sharing, translates into margin stability rather than only revenue stability. Until that happens, the large customer remains a critical revenue source, but not a source of calm.